Quadrant Capital Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-194
| Closed | -$2.38K | – | 2434 |
|
|
2025
Q1 | $2.38K | Sell |
194
-824
| -81% | -$10.1K | ﹤0.01% | 2487 |
|
|
2024
Q4 | $13.5K | Sell |
1,018
-1,661
| -62% | -$22K | ﹤0.01% | 2034 |
|
|
2024
Q3 | $51.6K | Buy |
2,679
+187
| +8% | +$3.6K | ﹤0.01% | 1435 |
|
|
2024
Q2 | $51.2K | Sell |
2,492
-75
| -3% | -$1.54K | ﹤0.01% | 1394 |
|
|
2024
Q1 | $61.1K | Buy |
2,567
+126
| +5% | +$3K | ﹤0.01% | 1277 |
|
|
2023
Q4 | $52.8K | Buy |
2,441
+1,496
| +158% | +$32.3K | ﹤0.01% | 1359 |
|
|
2023
Q3 | $13.7K | Buy |
945
+933
| +7,775% | +$13.5K | ﹤0.01% | 1867 |
|
|
2023
Q2 | $252 | Sell |
12
-116
| -91% | -$2.44K | ﹤0.01% | 2641 |
|
|
2023
Q1 | $2.7K | Hold |
128
| – | – | ﹤0.01% | 2371 |
|
|
2022
Q4 | $3.26K | Hold |
128
| – | – | ﹤0.01% | 2306 |
|
|
2022
Q3 | $3K | Hold |
128
| – | – | ﹤0.01% | 2298 |
|
|
2022
Q2 | $2K | Buy |
+128
| New | +$2K | ﹤0.01% | 2280 |
|